Quantcast

Old North News

Thursday, November 21, 2024

FDA conducted second highest number of inspections on Drugs companies in North Carolina during Q1 2023

Webp qdyp3hg0n6fiilgeuxkf5yj3s0lo

Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website

Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website

In the first quarter of 2023, 10 Drugs companies received 10 FDA inspections in North Carolina, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in North Carolina, equalling 16.1% of all inspections in the first quarter of 2023.

Of all the North Carolina companies involved in the Drugs sector, The Procter & Gamble Company received the most citations from the FDA in the first quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in North Carolina During Q1 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring101--
Blood and Blood Products10----
Compliance: Devices16--
Drug Quality Assurance--2--
Food Composition, Standards, Labeling and Econ91--
Foodborne Biological Hazards2051
Human Cellular, Tissue, and Gene Therapies21--
Postmarket Assurance: Devices52--
Tobacco Post-Market Activities4----
Vaccines and Allergenic Products10----

MORE NEWS